Resources

The Allergic Rhinitis Knowledge Centre hosts a number of resources which you may find useful for furthering your understanding of the condition and to assist with patient interaction. Click on these links to jump to useful links, videos, case studies and downloads.

Videos

Listed below are various short videos which cover:

  • Help your patients track their allergy symptoms and treatment with Allergy Diary by MACVIA-ARIA

  • Treatment with MP-Aze Flu seen to reduce allergic rhinitis disease severity
  • Sleep quality in persistent allergic rhinitis
  • Measuring the burden of allergic rhinitis: from the UK to Australia
  • The key features of the Allergy Diary application – download the app. by clicking here
  • How allergic rhinitis patients are likely to develop asthma
  • How to utilise combination therapies to enhance the effectiveness of treatment

 

  • Help your patients track their allergy symptoms and treatment with Allergy Diary by MACVIA-ARIA

    This video explains how to use the Allergy Diary by MACVIA-ARIA application, and how it allows patients to record daily allergy symptoms and track symptom control.

  • Treatment with MP-Aze Flu seen to reduce allergic rhinitis disease severity

    In this short video from SERIN Congress 2017, the study investigates the effectiveness of MP-AzeFlu in patients with persistent allergic rhinitis.

  • Sleep quality in persistent allergic rhinitis

    This video from EAACI Congress 2017 investigates sleep quality in patients with allergic rhinitis and how it improves with the use of MP-AzeFLu.

  • Measuring the burden of allergic rhinitis: from the UK to Australia

    Three posters are explored in this video, detailing the burden of allergic rhinitis and its impact on asthma in Australia.

  • Allergy diary

    Professor Jean Bousquet explains why the Allergy Diary app. is the ideal tool for a patient-centred approach to allergic rhinitis control.

  • Allergic rhinitis and asthma

    Doctor Glenis Scadding explains the connection between asthma and allergic rhinitis.

  • Allergic rhinitis treatment

    Professor Jean Bousquet discusses the issues with commonly prescribed combination therapies for allergic rhinitis.

  • How to use a nasal spray

    • How to use a nasal spray

      Click this link to view and download our infographic, giving concise and understandable instructions on how to effectively use a nasal spray.

    •  

      Useful links

      View up-to-date guidelines, reports and algorithms to assist you with the accurate diagnosis and treatment of your patients.


      AAAAI allergen immunotherapy guidelines

      This document was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology (JCAAI) and features key updates to specifications and guidelines for the treatment of patients. 


      ARIA 2008 report

      The 2008 revision of the ARIA Report, published as a Supplement in the European Journal of Allergy and Clinical Immunology, reviews the latest scientific evidence on the definition and classification of rhinitis, risk factors, mechanisms, and diagnosis and treatment, with extensive citations from the scientific literature.


      BSACI immunotherapy for allergic rhinitis guidelines

      Allergic rhinitis affects more than 20% of the population in the United Kingdom and Western Europe and represents a major cause of morbidity that includes interference with usual daily activities and impairment of sleep quality. This guidance prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) is for the management of AR in patients that have failed to achieve adequate relief of symptoms despite treatment with intranasal corticosteroids and/or antihistamines.


      MACVIA clinical decision algorithm

      The selection of pharmacotherapy for patients with allergic rhinitis is dependent on several factors, including age, symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment amendment may be required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control and are discussed by this paper.


       

Login/ Register Maximise Minimise